期刊文献+

肿瘤干细胞的耐药性与耐药机制 被引量:6

Drug resistance and its mechanisms of cancer stem cells
下载PDF
导出
摘要 背景:肿瘤干细胞不仅与肿瘤的多药耐药性有密切的关系,而且有着复杂的多药耐药机制。目的:对肿瘤干细胞及其耐药性和耐药机制的关系进行总结,为肿瘤的临床治疗提供新的思路。方法:应用计算机检索FMJS和Pubmed西文数据库检索(2003/2010),以"cancer stem cell,multiple drug resistance,apoptosis,cell cycle"为检索词;用计算机检索万方数据库(2000/2010),CNKI数据库(2000-2010)以"肿瘤;肿瘤干细胞;多药耐药性"为关键词。共收集到中文文献56篇,外文文献372篇。排除发表时间早、重复及类似研究,纳入29篇符合标准的文献。结果与结论:对干细胞的研究帮助人们加深对肿瘤的发生、发展及转移的认识。肿瘤组织中可能存在一小部分肿瘤细胞,与正常干细胞一样具有自我更新和无限增殖的能力,但具有特殊的耐药机制。肿瘤干细胞与肿瘤的发生及治疗关系密切。但针对肿瘤干细胞复杂的多药耐药机制尚有待进一步研究。 BACKGROUND:Tumor stem cells not only associate with multidrug resistance in cancer,and have a complex multi-drug resistance OBJECTIVE:To review correlation of cancer stem cells to drug resistance and resistance mechanisms,and to provide new ideas for clinical therapy of tumor. METHODS:We searched PubMed Western database and FMJS database (2003-2010) with the key words of "cancer stem cell,multiple drug resistance,apoptosis,cell cycle". Wanfang database (2000-2010) and CNKI database (2000-2010) were searched by computer with the key words of "tumor,cancer stem cells,multidrug resistance". A total of 56 Chinese literatures,372 foreign languages literatures were collected. Published earlier,repeated and similar studies were excluded and 29 literatures were included. RESULTS AND CONCLUSION:Stem cell research helps people deepen their knowledge of tumor occurrence,development and transfer. Tumor tissues have a small part of tumor cells that have self-renewal and unlimited proliferation ability as normal stem cells,but have a special mechanism of resistance. Tumor stem cells are closely related to tumor occurrence and treatment. However,complex multi-drug resistance of cancer stem cells requires further studies.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第1期116-119,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献23

  • 1Reya T, Morrison S J, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001 ;414(6859):105-111.
  • 2Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367(6464):645-648.
  • 3AI-Hajj M,Wicha MS, Benito-Hernandez A, et al. Prospective I dentification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100(7):3983-3988.
  • 4Jordan CT. Cancer stem cell biology: from leukemia to solid tumors. Curr Opin Cell Biol. 2004;16(6):708-712,.
  • 5Shackleton M, Quintana E, Fearon ER, et al. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009; 138(5):822-829.
  • 6Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance.Nat Rev Cancer. 2005;5(4):275-284.
  • 7Takara K, Sakaeda T, Okumura K. An update on overcoming MDRl-mediated multidrug resistance in cancer chemotherapy, Curr Pharm Des. 2006;12(3):273-286.
  • 8Koshiji M, To KK, Hammer S, et al. HIF-lalpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell. 2005;17(6):793-803.
  • 9Bunting KD, Zhou S, Lu T, et al.Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood. 2000;96(3):902-909.
  • 10Jonker JW, Freeman J, Bolscher E, et al. Contribution of the ABC transporters Bcrpl and Mdrla/1 b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells. 2005;23(8):1059-1065.

同被引文献79

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部